| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 7 | -532,053 | 100% | $21.00 | -$11,171,069 |
| Net | -7 | -532,053 | -100% | -$11,171,069 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 10%+ Owner | $345,672,360 | 18 Feb 2025 | ||
| TERRY J. ROSEN | Chief Executive Officer, Director | $53,293,626 | -$1,203,959 | -2.2% | 23 Jan 2026 |
| Juan C. Jaen | President | $30,961,174 | -$6,309,802 | -17% | 23 Jan 2026 |
| YASUNORI KANEKO | Director | $7,732,309 | 10 Jun 2025 | ||
| Jennifer Jarrett | Chief Operating Officer | $5,437,414 | -$2,171,347 | -29% | 23 Jan 2026 |
| Carolyn C. Tang | General Counsel | $3,544,331 | -$318,496 | -8.2% | 23 Jan 2026 |
| II Robert C. Goeltz | Chief Financial Officer | $2,190,548 | -$656,925 | -23% | 23 Jan 2026 |
| Richard Markus | Chief Medical Officer | $2,136,288 | -$210,144 | -9% | 23 Jan 2026 |
| Nuyten Dimitry SA | Chief Medical Officer | $1,407,289 | 15 Dec 2024 | ||
| KATHRYN E. FALBERG | Director | $1,386,132 | 10 Jun 2025 | ||
| Alexander Azoy | Chief Accounting Officer | $943,215 | -$300,395 | -24% | 23 Jan 2026 |
| David L. Lacey | Director | $576,130 | 10 Jun 2025 | ||
| Antoni Ribas | Director | $423,888 | 10 Jun 2025 | ||
| William Grossman | Chief Medical Officer | $414,460 | 16 Jun 2021 | ||
| ANDREW J. PERLMAN | Director | $346,115 | 10 Jun 2025 | ||
| Patrick Machado | Director | $313,432 | 10 Jun 2025 | ||
| Nicole Lambert | Director | $302,876 | 10 Jun 2025 | ||
| Johanna Mercier | Director | $0 | 29 Jan 2024 | ||
| Dietmar Berger | Director | $0 | 06 Feb 2025 | ||
| Linda Slanec Higgins | Director | 10 Aug 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|